Clinical trial
Effects of Endotoxin in Normal Human Volunteers
NCT00001303 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00001303 |
|---|---|
| Title | Effects of Endotoxin in Normal Human Volunteers |
| Official title | The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, Lung Disease, Sepsis, Septic Shock |
| Intervention type | Drug |
| Interventions | Reference Endotoxin, Inhaled Nitric Oxide |
| Enrollment | 198 |
| Start date | Apr 6, 1992 |
| Primary completion | Mar 21, 2007 |
| Completion | May 17, 2018 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: